Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2010-022874-15Phase 4Completed
Phase 4 trial of nitrous oxide and nimodipine in cerebral vasospasm (2 arms), sponsored by University of Nottingham. Primary endpoint: Cerebral autoregulation. Started Oct 2010; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2010-022874-15.